Vir Biotechnology Inc. (VIR) Prices 7.14M Share Common Offering at $42/Sh

Vir Biotechnology, Inc. (NASDAQ: VIR) today announced the pricing of its previously announced underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $42.00 per share. The gross proceeds to Vir from the offering before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $300.0 million. The offering is expected to close on July 10, 2020, subject to satisfaction of customary closing conditions. In addition, Vir has granted the underwriters a 30-day option to purchase up to 1,071,428 additional shares of its common stock.

Goldman Sachs & Co. LLC, BofA Securities, Cowen and Barclays are acting as joint book-running managers for the offering. Needham & Company is acting as lead-manager for the offering.

Registration statements relating to these securities have been filed with the Securities and Exchange Commission (SEC) and became effective on July 7, 2020.

You May Also Be Interested In

• Jupiter Neurosciences prices $2M registered direct offering of shares
• CoStar Group acquires Zonda for $800M, adding new home data
• EShallGo closes $1.75M registered direct offering at $1 per share